Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 4/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.37 |
| ▸ | BPTF | Q12830 | 1/20 | 0.37 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13429111 | 0.88 | HDAC6 (0.44) | ALDH1A1 | |
| SCHEMBL13428589 | 0.82 | ALDH1A1 (0.46) | ALDH1A1PIM2RAB9AP4HTM | |
| Hydrochloric Acid SCHEMBL3227374 | 0.82 | ALDH1A1 (0.47) | ALDH1A1PIM2RAB9AP4HTM | |
| Hydrochloric Acid SCHEMBL3227383 | 0.82 | ALDH1A1 (0.47) | ALDH1A1PIM2RAB9AP4HTM | |
| SCHEMBL13428506 | 0.81 | BPTF (0.42) | RAB9AFLT3CSNK2A1CSNK2A2CSNK2B | |
| SCHEMBL13429117 | 0.81 | HDAC6 (0.42) | ALDH1A1PIM2FLT3 | |
| SCHEMBL13428585 | 0.81 | ALDH1A1 (0.44) | ALDH1A1PIM2RAB9ACSNK2A1CSNK2A2 | |
| SCHEMBL13428825 | 0.80 | ALDH1A1 (0.51) | ALDH1A1PIM2RAB9AP4HTM | |
| SCHEMBL13428579 | 0.78 | ALDH1A1 (0.42) | ALDH1A1PIM2RAB9ACSNK2A1CSNK2A2 | |
| SCHEMBL3225269 | 0.77 | RAB9A (0.49) | ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100069388-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100069388-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069388-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | HDAC1, HDAC11, HDAC2 | ALDH1A1 1516/4885PIM2 4195/4885RAB9A 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.